Unexpected response of extramedullary plasmacytoma in patients with lung cancer who received nivolumab von Yamaguchi, Ou, Kaira, K., Nakamura, Y., Kagamu, H.

Volltext

A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance... von Mouri, A., Kisohara, A., Morita, R., Ko, R., Nakagawa, T., Makiguchi, T., Isobe, K., Ishikawa, N., Kondo, T., Akiyama, M., Bessho, A., Honda, R., Yoshimura, K., Kagamu, H., Kato, S., Kobayashi, K., Kaira, K., Maemondo, M.

Volltext

IL-17 eliminates therapeutic effects of oral tolerance in murine airway allergic inflammation von Kawakami, H., Koya, T., Kagamu, H., Kimura, Y., Sakamoto, H., Yamabayashi, C., Furukawa, T., Sakagami, T., Miyabayashi, T., Hasegawa, T., Suzuki, E., Narita, I.

Volltext

3065 A phase II study of chemotherapy combined with bevacizumab for patients with malignant pleural effusions: North East Japan Lung Cancer Study Group Trial NEJ013A von Sugawara, S, Usui, K, Nishitsuji, M, Fujita, Y, Inoue, A, Mouri, A, Watanabe, H, Sakai, H, Kinoshita, I, Ohhara, Y, Maemondo, M, Kagamu, H, Hagiwara, K

Volltext

676P NEJ053C: A phase II study of nivolumab and ipilimumab combined with chemotherapy after lung stereotactic body radiotherapy as first-line therapy for stage IV non-small cell lu... von Watanabe, K., Ito, K., Sumi, T., Fujii, O., Imai, H., Kaira, K., Murofushi, K. Nemoto, Kato, S., Morita, S., Kagamu, H., Kobayashi, K., Hosomi, Y.

Volltext

654P Efficacy and safety of first-line ipilimumab and nivolumab treatment in elderly patients with non-small cell lung cancer von Imai, H., Mouri, A., Endo, S., Tsukamoto, K., Masaki, K., Hashimoto, K., Miura, Y., Shiono, A., Yamaguchi, O., Nakagawa, J., Kaira, K., Kobayashi, K., Kagamu, H.

Volltext

A prostacyclin agonist with thromboxane inhibitory activity for airway allergic inflammation in mice von Hayashi, M., Koya, T., Kawakami, H., Sakagami, T., Hasegawa, T., Kagamu, H., Takada, T., Sakai, Y., Suzuki, E., Gelfand, E. W., Gejyo, F.

Volltext

EP08.03-02 Nivolumab Plus Ipilimumab in Relapsed Stage III Non-Small Cell Lung Cancer After Durvalumab Following Chemoradiotherapy von Tokito, T., Mouri, A., Watanabe, S., Nagai, Y., Imai, H., Yamaguchi, O., Saida, Y., Kobayashi, K., Kaira, K., Kagamu, H.

Volltext

1078P Correlation between T cell immunity and EGFR-TKI treatment in patients harboring EGFR driver mutation von Mouri, A., Kaira, K., Yamaguchi, O., Shiono, A., Miura, Y., Hashimoto, K., Nishihara, F., Imai, H., Kobayashi, K., Kagamu, H.

Volltext

9087 POSTER Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited Prior Gefitinib Therapy von Watanabe, S, Saida, Y, Ichikawa, K, Koshio, J, Baba, J, Miura, S, Tanaka, J, Kagamu, H, Narita, I, Yoshizawa, H

Volltext

1108 POSTER DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 3, X-linked is a CD133+ Tumour-specific Protein and Induces Antitumour Immunity von Ichikawa, K, Kagamu, H, Koshio, J, Saida, Y, Miura, S, Watanabe, S, Tanaka, J, Yoshizawa, H, Narita, I

Volltext

1067P Discovery of a new CD4+ T cell cluster that correlates PD-1 blockade efficacy von Kagamu, H., Yamasaki, S., Horimoto, K., Kitano, S., Yamaguchi, O., Mouri, A., Shiono, A., Miura, Y., Hashimoto, K., Imai, H., Kaira, K., Kobayashi, K.

Volltext

1292MO A phase II study of daily carboplatin plus irradiation followed by durvalumab for unresectable III non-small cell lung cancer patients with PS 2 or elderly (≧75 years): NEJ0... von Ko, R., Mouri, A., Kisohara, A., Morita, R., Nakagawa, T., Makiguchi, T., Isobe, K., Ishikawa, N., Kondo, T., Akiyama, M., Bessho, A., Honda, R., Yoshimura, K., Kagamu, H., Kato, S., Kobayashi, K., Kaira, K.

Volltext

Appropriate Timing of CD40 Ligation for RNA-Pulsed DCs to Induce Antitumor Immunity von Miura, S, Kagamu, H, Tanaka, H, Yoshizawa, H, Gejyo, F

Volltext

1446P - Immunological impact of surgery in NSCLC patients von Yanagihara, A., Kagamu, H., Sakaguchi, H., Ishida, H., Nitanda, H., Taguchi, R., Yoshimura, R., Yamaguchi, O., Hashimoto, K., Kodaira, K.

Volltext

Immunological impact of surgery in NSCLC patients von Yanagihara, A., Kagamu, H., Sakaguchi, H., Ishida, H., Nitanda, H., Taguchi, R., Yoshimura, R., Yamaguchi, O., Hashimoto, K., Kodaira, K.

Volltext

1446PImmunological impact of surgery in NSCLC patients von Yanagihara, A, Kagamu, H, Sakaguchi, H, Ishida, H, Nitanda, H, Taguchi, R, Yoshimura, R, Yamaguchi, O, Hashimoto, K, Kodaira, K

Volltext

568P First-line (1L) osimertinib + platinum-pemetrexed in EGFR-mutated (EGFRm) advanced NSCLC: Updated FLAURA2 safety run-in (SRI) results von Planchard, D., Poltoratskiy, A., Kim, S-W., Kim, T.M., Yanagitani, N., Kagamu, H., Feng, P-H., Hughes, B., Yang, T-Y., Yang, J.C-H., Lee, C.K., Karaseva, N., Mitchell, P., Tambo, Y., Armenteros Monterroso, E., Todd, A., Sahasrabudhe, A., Jänne, P.A., Kobayashi, K.

Volltext

A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Ja... von Osaki, Akihiko, Inoue, Kenichi, Sakai, Hiroshi, Yamada, Kazuhiko, Minato, Koichi, Ohyanagi, Fumiyoshi, Tokuda, Yutaka, Ikeda, Norihiko, Kagamu, Hiroshi, Kubota, Kaoru, Tamura, Tomohide, Saeki, Toshiaki

Volltext

1468P - Effector CD4+ T-cell induction by thoracic radiotherapy for patients with NSCLC von Miura, Y., Kodaira, K., Kenmochi, M., Yamashiro, T., Yamaguchi, O., Shiono, A., Mouri, A., Nishihara, F., Shinomiya, S., Hashimoto, K., Murayama, Y., Kobayashi, K., Kaira, K., Kagamu, H.

Volltext